GC Wealth Management RIA’s Wyndham Hotels & Resorts WH Stock Holding History

GC Wealth Management RIA’s Portfolio WH Stock Details WH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-2,760	Closed	-$221K	–	854
2025 Q3	$221K	Buy	+2,760	New	+$238K	0.01%	793

Other funds holding WH

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

GC Wealth Management RIA's WH Position: Q4 2025 in Review

GC Wealth Management RIA sold out of Wyndham Hotels & Resorts (WH) in Q4 2025, closing a stake of 2,760 shares — an estimated $221K sold.

GC Wealth Management RIA first reported a position in WH in Q3 2025 and held it in 1 quarter. The position peaked at $221K in Q3 2025. 426 funds tracked by Wall St. Rank hold WH as of Q4 2025.

GC Wealth Management RIA reported no remaining Wyndham Hotels & Resorts position as of Q4 2025 after selling out during the quarter.
GC Wealth Management RIA sold 2,760 Wyndham Hotels & Resorts shares in Q4 2025, an estimated $221K.
GC Wealth Management RIA first reported a position in Wyndham Hotels & Resorts in Q3 2025 and held it in 1 quarter.
GC Wealth Management RIA's Wyndham Hotels & Resorts position peaked at $221K in Q3 2025.
426 funds tracked by Wall St. Rank held Wyndham Hotels & Resorts as of Q4 2025.

Based on GC Wealth Management RIA's 13F filing for Q4 2025, filed 30 Jan 2026.